NAD+ 500mg – Nicotinamide Adenine Dinucleotide

Chemical diagram for NAD+ source: https://en.wikipedia.org/wiki/Nicotinamide_adenine_dinucleotide#/media/File:NAD+.svg

KEY SPECIFICATIONS

PRODUCT OVERVIEW

NAD+ (Nicotinamide Adenine Dinucleotide) is a fundamental coenzyme present in all living cells, serving dual roles as electron carrier in redox reactions and essential substrate for regulatory enzymes including sirtuins and PARPs. As a central component of cellular energy metabolism, NAD+ is critical for oxidative phosphorylation, DNA repair, and epigenetic regulation. Research demonstrates NAD+ levels decline 10-80% across tissues with aging, driven by increased CD38/PARP activity and reduced NAMPT expression—contributing to mitochondrial dysfunction, sirtuin hypoactivity, and cellular senescence in experimental models. NAD+ supplementation studies activate SIRT1/SIRT3, enhance mitochondrial biogenesis, and improve oxidative phosphorylation parameters. BIONIX supplies NAD+ with ≥99% purity for metabolic, aging, and biochemical research applications.

MECHANISM OF ACTION

NAD+ functions through two primary mechanisms: electron carrier in redox reactions and consumable substrate for regulatory enzymes controlling cellular metabolism, DNA repair, and stress responses.

Sirtuin-Mediated Deacetylation (SIRT1-7):

Metabolic Pathways and ATP Generation:

NAD+-Consuming Enzymes:

Redox Cycling (NAD+ vs NADH):

NAD+ Biosynthesis Pathways:

Proposed Mechanism Cascade:

NAD+ Availability → Sirtuin Activation → PGC-1α Deacetylation → 
Mitochondrial Biogenesis / FOXO Activation → Stress Resistance Genes / 
PARP Activity → DNA Repair Capability / CD38 Activity → NAD+ Depletion (aging)

Comparative Profile:

RESEARCH APPLICATIONS

• Mitochondrial Function and Metabolism: Oxygen consumption rate (OCR) analysis via Seahorse XF platform, NAD+/NADH ratio determination through enzymatic assays and LC-MS, ATP production quantification via luciferase assays, mitochondrial membrane potential assessment (JC-1, TMRM), Complex I activity measurement via spectrophotometric analysis. Investigation of respiratory chain function, mitochondrial biogenesis, and coupling efficiency between catabolism and oxidative phosphorylation.

• Cellular Aging and Senescence: Senescence marker analysis including β-galactosidase activity, p16INK4a/p21 expression, senescence-associated secretory phenotype (SASP) quantification, and telomere dysfunction-induced foci (TIF) assessment. Aging model systems: replicative senescence in fibroblasts, stress-induced premature senescence, Werner syndrome (WRN knockout) models, and Hutchinson-Gilford progeria models. Research demonstrates NAD+ precursor supplementation restores mitochondrial NAD+ and salvage enzyme expression (NAMPT/NMNAT1), reducing senescence markers.

• Neurodegeneration Research: Alzheimer’s model investigations of mitochondrial dysfunction, cognition parameters, and oxidative stress markers. Parkinson’s research focusing on dopaminergic neuron survival and energy metabolism. ALS studies examining motor neuron protection and axonal transport. Ataxia-telangiectasia research on neuromotor coordination. Studies show dose-dependent brain NAD+ increases with supplementation, correlating with improved mitochondrial health, reduced oxidative stress, and enhanced autophagy.

• Inflammation and Immune Function: NF-κB pathway regulation through SIRT1-mediated p65/RelA deacetylation, reducing transcriptional activity and pro-inflammatory cytokine expression (TNF-α, IL-6, IL-1β). Macrophage polarization studies (M1/M2 balance), dendritic cell maturation analysis, and T cell exhaustion/metabolism investigations. Research demonstrates intracellular NAD+ availability correlates with pro/anti-inflammatory response balance in immune cell populations.

• DNA Repair and Genomic Stability: PARP-dependent DNA damage response kinetics analysis, PARP inhibitor combination studies, genomic instability model investigations, and replication stress analysis under controlled conditions. Research examines interplay between DNA repair capacity and cellular energy metabolism through NAD+ availability modulation.

• Metabolic Flux and Biosynthesis: Salvage pathway flux analysis measuring NAMPT/NMNAT enzyme activity, de novo pathway investigation via tryptophan metabolism studies, and Preiss-Handler pathway assessment through niacin supplementation models. CD38-mediated NAD+ consumption research in aging and inflammatory contexts.

ANALYTICAL VERIFICATION

BIONIX NAD+ Coenzyme undergoes comprehensive analytical characterization:

• HPLC Analysis: Gradient separation with UV detection confirming ≥99% purity; separates NAD+ from nicotinamide, ADP-ribose, and degradation products • Mass Spectrometry: Exact molecular weight confirmation (663.43 g/mol) and molecular structure verification (C₂₁H₂₇N₇O₁₄P₂) • Identity Confirmation: NAD+ vs NADH differentiation, dinucleotide structure validation • Water Content: Karl Fischer analysis • Residual Solvent Testing: Manufacturing process validation • Stability Verification: Redox state assessment

Physical Characteristics:

DEVELOPMENT STATUS

• Natural Occurrence: Endogenous coenzyme present in all living cells; essential for life • Research History: 100+ years of biochemical investigation; fundamental to metabolic biology • Clinical Applications: Not FDA or EMA approved as therapeutic agent; research compound only • Current Research: Mitochondrial function, aging biology, neurodegeneration, metabolic disease • Recent Findings: 2025 Werner syndrome research; CD38 inhibition studies; NAD+ precursor comparisons • Regulatory Status: Endogenous metabolite; research use only • WADA Status: Research compound (verify current prohibited list)

BIONIX NAD+ is supplied exclusively for laboratory research purposes—not for therapeutic use, human administration, veterinary, or clinical applications.

FREQUENTLY ENCOUNTERED INQUIRIES

What role does NAD+ play in energy metabolism?

NAD+ functions as an essential electron acceptor in redox reactions of glycolysis and the citric acid cycle. Research demonstrates correlations between NAD+ availability and mitochondrial parameters including oxidative phosphorylation capacity, ATP production, and respiratory chain function. As the primary electron carrier in over 400 enzymatic reactions, NAD+ is reduced to NADH during catabolic reactions and regenerated at Complex I of the electron transport chain, coupling electron flow to ATP synthesis through chemiosmosis (~2.5 ATP per NADH).

How does NAD+ function as a sirtuin substrate?

Sirtuins (SIRT1-7) are NAD+-dependent deacetylases that consume one NAD+ molecule per deacetylation reaction, producing nicotinamide and O-acetyl-ADP-ribose. This consumption couples sirtuin activity directly to cellular metabolic state—when NAD+ is abundant, sirtuin activity is high; when NAD+ is depleted, sirtuin function is impaired. SIRT1 and SIRT3 are particularly important for PGC-1α deacetylation (mitochondrial biogenesis), FOXO activation (stress resistance), and NF-κB regulation (inflammation control).

How is NAD+ used in aging research?

Transcriptome analyses in aging-relevant models report differential expression patterns of nuclear and mitochondrial genes associated with altered NAD+ levels. Research demonstrates NAD+ declines 10-80% in various tissues with age, driven by increased CD38/PARP activity and reduced NAMPT expression. This decline correlates with impaired sirtuin activity, mitochondrial dysfunction, and cellular senescence. Studies show NAD+ precursor supplementation restores mitochondrial NAD+ and salvage enzyme expression (NAMPT/NMNAT1), reducing senescence markers in Werner syndrome and progeria models.

What is the relationship between NAD+ and DNA repair?

PARPs (Poly(ADP-ribose) polymerases) consume NAD+ during DNA damage response, using it to synthesize poly(ADP-ribose) chains that recruit repair machinery to strand breaks. Excessive DNA damage can lead to PARP hyperactivation and NAD+ depletion, creating a feedback loop of metabolic dysfunction. Research investigates this interplay between DNA repair capacity and cellular energy metabolism through NAD+ availability modulation, particularly in contexts of genomic instability and replication stress.

What applications does NAD+ have in neurodegeneration research?

In mouse models of neurodegenerative diseases, NAD+ supplementation is associated with neuron survival markers, oxidative stress indicators, and mitochondrial parameters. Studies in Alzheimer’s models demonstrate dose-dependent increases in brain NAD+ correlating with improved mitochondrial health, reduced oxidative damage, and enhanced autophagy markers. Parkinson’s disease research focuses on dopaminergic neuron survival and energy metabolism. Applications are limited to preclinical model systems.

What are the NAD+ biosynthesis pathways?

Three primary pathways synthesize NAD+: (1) Salvage pathway (~85% of synthesis) using nicotinamide via NAMPT (rate-limiting) and NMNAT enzymes—primary recycling route; (2) De novo pathway from tryptophan through quinolinic acid—low efficiency, important in liver/kidney; (3) Preiss-Handler pathway from nicotinic acid via NAPRT and NMNAT—utilizes dietary niacin. Understanding these pathways is essential for metabolic flux studies and aging research investigating NAD+ decline mechanisms.

REFERENCES

• PMID: 26785480 — NAD+ in aging, metabolism, and neurodegeneration (Science, 2015)
• PMID: 22682224 — NAD+ precursor nicotinamide riboside enhances oxidative metabolism (Cell Metab, 2012)
• PMID: 29514064 — NAD+ intermediates: biology and therapeutic potential of NMN and NR (Cell Metab, 2018)
• PMID: 26956191 — NAD+ and sirtuins in aging and disease (Trends Cell Biol, 2014)
• PMID: 27322007 — CD38 dictates age-related NAD decline via SIRT3-dependent mechanism (Cell Metab, 2016)
• PMC, 2025 — Promising results with NAD supplementation in rare diseases
• Multiple studies — NAD+ redox cycling in over 400 enzymatic reactions